Efficacy of first‐line treatment options beyond RET‐TKIs in advanced RET‐rearranged non‐small cell lung cancer: A multi‐center real‐world study

Documenti analoghi

• Prognostic impact of the timing of immunotherapy in first‐line immunochemotherapy for patients with advanced lung adenocarcinoma: A propensity score‐matched analysis
  di: Yanxin Sun, et al.
  Pubblicazione: (2025)
• ILT4 facilitates angiogenesis in non‐small cell lung cancer
  di: Shuyun Wang, et al.
  Pubblicazione: (2024)
• Panel Testing of BRAF Mutation, RAS Mutation, and RET/PTC Rearrangements or RET Mutation Using Fine‐Needle Aspiration Specimens in Evaluation of Thyroid Carcinoma
  di: Zhaohui Zhu, et al.
  Pubblicazione: (2025)
• Dual targeting of RET and SRC synergizes in RET fusion‐positive cancer cells
  di: Juhyeon Son, et al.
  Pubblicazione: (2025)
• Absence of RET/PTC1 rearrangement in a sample of Colombian individuals with papillary thyroid carcinoma
  di: Cladelis Rubio-Gómez
  Pubblicazione: (2019)